Protein-C Test at Ayzal Lab

Protein-C Test at Ayzal Lab

The Protein-C test at Ayzal Lab in Lahore, Pakistan, is a highly specialized hematological investigation designed to measure the concentration and functional activity of Protein C in the blood. Protein C is a vitamin K-dependent glycoprotein synthesized by the liver that plays a pivotal role in regulating the body’s natural anticoagulation system. By inactivating specific coagulation factors, namely Factor Va and Factor VIIIa, active Protein C prevents excessive blood clot formation (thrombosis). Evaluating this protein is essential for diagnosing inherited or acquired deficiencies that predispose patients to life-threatening thrombotic disorders, such as deep vein thrombosis (DVT) and pulmonary embolism (PE).

At Ayzal Lab, this laboratory investigation is performed using advanced automated coagulation analyzers. The test utilizes a venous blood sample to determine whether a patient has a quantitative deficiency (Type I, where the total amount of Protein C is reduced) or a qualitative deficiency (Type II, where the protein is present in normal amounts but does not function correctly). Understanding the functional capacity of this physiological anticoagulant is critical for clinical decision-making, particularly in patients with a personal or strong family history of unexplained blood clots, recurrent miscarriages, or neonatal purpura fulminans.

The clinical importance of the Protein-C test lies in its ability to identify individuals at high risk for hypercoagulable states, also known as thrombophilia. Identifying a deficiency allows hematologists and physicians at Ayzal Lab to implement targeted prophylactic strategies, manage long-term anticoagulation therapy, and offer genetic counseling when hereditary deficiencies are suspected. This diagnostic value is particularly crucial before major surgical procedures, during pregnancy, or when evaluating patients who experience recurrent thrombotic events without obvious provoking factors.

Clinical Procedure: What to Expect

Patient Preparation

To ensure highly accurate and clinically reliable results for your Protein-C test at Ayzal Lab, patients must adhere to specific preparation guidelines:

• Fasting Requirements: While a strict overnight fast is not always mandatory, a fasting period of 8 to 12 hours is highly recommended to prevent lipemia (excess fat in the blood), which can interfere with optical coagulation testing methods.
• Medication Discontinuation: It is absolutely critical to inform your prescribing physician and the laboratory staff about all medications you are currently taking. Oral anticoagulants, particularly Warfarin (Coumadin), directly affect vitamin K-dependent proteins and will significantly lower Protein C levels, leading to inaccurate results. Typically, testing is postponed until the patient has been off Warfarin therapy for at least two weeks.
• Heparin and Direct Oral Anticoagulants (DOACs): Heparin, Rivaroxaban, Apixaban, and other modern anticoagulants can also interfere with functional Protein C assays. Your physician will advise you on when to safely pause these medications prior to sample collection.
• Timing of the Test: The test should not be performed during an active, acute thrombotic event or while the patient is undergoing active inflammatory responses, as these conditions temporarily deplete circulating Protein C levels, leading to a false-positive diagnosis of deficiency. Testing is ideally scheduled 3 to 6 months after a thrombotic episode has resolved.
• Hydration: Drink plenty of water before the test to ensure adequate hydration, which makes venous access easier for the phlebotomist.

During the Procedure

The collection of a blood sample for a Protein-C assay at Ayzal Lab is a standard, safe, and quick phlebotomy procedure conducted by experienced medical laboratory technicians:

• Patient Positioning: You will be asked to sit comfortably in a specialized phlebotomy chair. The technician will ask you to extend your arm, resting it on a supportive surface.
• Site Selection and Preparation: The technician will inspect your arm to locate a suitable vein, typically in the antecubital fossa (the bend of the elbow). The selected site is thoroughly cleansed with an antiseptic alcohol swab to prevent contamination.
• Tourniquet Application: A sterile elastic tourniquet is tied around your upper arm to restrict blood flow temporarily, causing the veins to swell and become more visible and accessible.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube containing sodium citrate (light blue top) is gently inserted into the vein. Sodium citrate is the standard anticoagulant used for coagulation studies as it preserves clotting factors.
• Sample Collection: The blood is drawn into the tube. It is crucial that the tube is filled completely to the marked line to maintain the precise 9:1 ratio of blood to anticoagulant required for accurate testing.
• Needle Removal and Pressure: Once the sample is collected, the tourniquet is released, the needle is gently withdrawn, and a sterile cotton ball or gauze is pressed onto the puncture site to stop any bleeding. An adhesive bandage is then applied.
• Duration and Safety: The entire venipuncture process takes less than five minutes. It is highly safe, with minimal discomfort akin to a brief pinch. The sample is immediately inverted gently several times to mix the blood with the citrate anticoagulant and sent to the laboratory for processing.

When is a Protein-C Test Performed?

Evaluating Unexplained Deep Vein Thrombosis

Physicians frequently order a Protein-C test when a patient presents with unexplained deep vein thrombosis (DVT), particularly at a young age (under 50 years). DVT involves the formation of blood clots in the deep veins of the body, usually in the legs, presenting with symptoms such as localized pain, swelling, warmth, and redness. When these clots occur without clear provoking risk factors like major surgery, prolonged immobilization, or severe trauma, an underlying hereditary thrombophilia such as Protein C deficiency is strongly suspected. Identifying this deficiency helps clinicians determine the duration and intensity of anticoagulant therapy.

Investigating Pulmonary Embolism

A pulmonary embolism (PE) is a life-threatening medical emergency that occurs when a blood clot breaks free from a deep vein and travels to the lungs, blocking a pulmonary artery. Symptoms include sudden shortness of breath, sharp chest pain that worsens with deep breathing, rapid heart rate, and coughing up blood. When a patient survives an unprovoked PE, a comprehensive thrombophilia panel, including a Protein-C test, is performed at Ayzal Lab to identify if a physiological anticoagulant deficiency was the root cause, helping to prevent catastrophic recurrent episodes.

Assessing Recurrent Miscarriages and Pregnancy Complications

Undiagnosed hypercoagulable states can lead to microvascular thrombosis in the placenta, restricting blood flow to the developing fetus. This can result in recurrent pregnancy loss (typically defined as three or more consecutive miscarriages), preeclampsia, intrauterine growth restriction (IUGR), or placental abruption. Obstetricians recommend a Protein-C test as part of a recurrent pregnancy loss workup to evaluate if a maternal clotting disorder is present, allowing for the implementation of low-molecular-weight heparin (LMWH) therapy in subsequent pregnancies to improve outcomes.

Diagnosing Warfarin-Induced Skin Necrosis

When patients with an unrecognized, underlying Protein C deficiency begin oral anticoagulation therapy with Warfarin, they can experience a rare but severe complication known as Warfarin-induced skin necrosis. Because Protein C has a shorter half-life than other vitamin K-dependent clotting factors, initiating Warfarin causes a rapid, transient drop in Protein C levels before the procoagulant factors decline. This creates a temporary hypercoagulable state, leading to microvascular thrombosis and localized tissue death (necrosis), typically in the breasts, thighs, or buttocks. A Protein-C test is critical in confirming this diagnosis and guiding alternative anticoagulation strategies.

Screening Family Members of Affected Individuals

Hereditary Protein C deficiency is an autosomal dominant genetic disorder. If an individual is diagnosed with a genetic Protein C deficiency, clinical guidelines recommend screening first-degree relatives, especially those who are planning pregnancies, undergoing major surgeries, or considering oral contraceptive use. Identifying asymptomatic carriers allows healthcare providers to recommend proactive thromboprophylaxis during high-risk periods, significantly reducing their lifetime risk of developing dangerous thromboembolic complications.

What Does a Protein-C Test Detect?

The Protein-C test at Ayzal Lab is designed to detect quantitative and qualitative abnormalities in the Protein C pathway. Specifically, the test can identify:

• Congenital Protein C Deficiency (Type I): Characterized by a simultaneous decrease in both Protein C antigen levels and functional activity.
• Congenital Protein C Deficiency (Type II): Characterized by normal antigen levels but significantly reduced functional activity, indicating a dysfunctional protein.
• Acquired Protein C Deficiency: Temporary or permanent decreases in Protein C levels due to underlying medical conditions rather than genetic mutations.
• Severe Neonatal Purpura Fulminans: A rare, life-threatening condition in newborns homozygous for Protein C deficiency, presenting with widespread microvascular thrombosis and skin necrosis shortly after birth.
• Hepatic Dysfunction: Reduced synthesis of Protein C due to severe liver diseases such as cirrhosis, hepatitis, or liver failure, as the liver is the primary site of Protein C production.
• Vitamin K Deficiency: Since Protein C synthesis requires vitamin K, insufficient dietary intake, malabsorption syndromes, or vitamin K antagonists (like Warfarin) lead to decreased functional Protein C.
• Disseminated Intravascular Coagulation (DIC): An acute, life-threatening consumption coagulopathy where widespread clotting depletes natural anticoagulants, including Protein C.
• Severe Sepsis and Systemic Infection: Inflammatory cytokines downregulate the endothelial Protein C receptor and thrombomodulin, leading to accelerated consumption and decreased levels of active Protein C.
• Post-Operative Depletion: Temporary reduction in Protein C levels following major surgical procedures due to localized consumption at wound sites.
• Active Thrombotic States: Temporary consumption of Protein C during an acute deep vein thrombosis or pulmonary embolism.
• Renal Disease: Conditions like nephrotic syndrome can lead to the loss of low-molecular-weight proteins, including clotting regulators, in the urine.
• Estrogen-Induced Alterations: Mild decreases in Protein C activity associated with high-dose oral contraceptive use or hormone replacement therapy.

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that timely diagnostic results are crucial for effective clinical management, especially when dealing with potential clotting disorders. The Protein-C test requires specialized processing, including plasma separation and precise coagulation assays. Typically, the verified test report is available within 24 to 48 hours of sample collection.

Once the clinical pathologists at Ayzal Lab review and verify the findings, patients receive an automated SMS notification. Reports can be accessed online through the official Ayzal Lab patient portal or mobile application, allowing patients and their referring physicians to view, download, and print the results from the comfort of their homes. Physical copies of the reports can also be collected directly from the Ayzal Lab reception desk.

Protein-C Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Protein C Functional Activity	70% to 140% (may vary slightly by assay)	Decreased activity (<70%) indicating hereditary or acquired deficiency; increased activity (rarely clinically significant).
Protein C Antigen Level	70% to 140%	Decreased antigen levels indicating Type I deficiency; normal antigen with low activity indicates Type II deficiency.
Vitamin K Status	Normal systemic levels	Deficiency leads to reduced functional Protein C and prolonged clotting times (PT/INR).
Liver Synthetic Function	Normal albumin and clotting factors	Impaired synthesis due to liver disease leads to decreased Protein C levels.
Coagulation System Balance	Balanced procoagulant and anticoagulant pathways	Consumption of Protein C during acute thrombosis or disseminated intravascular coagulation (DIC).

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Protein-C Test?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists and technologists specializing in hematology and coagulation disorders.
• Patient-Focused Care: We prioritize patient comfort, safety, and clear communication throughout the testing process.
• Quality Diagnostic Services: Ayzal Lab utilizes state-of-the-art automated coagulation analyzers to ensure high precision and reproducibility of results.
• Professional Reporting: Our reports are comprehensive, easy to read, and structured to assist clinicians in making rapid, accurate diagnoses.
• Modern Diagnostic Approach: We employ evidence-based laboratory protocols and strict internal quality control measures.
• Comfortable Environment: Our collection centers in Lahore are designed to provide a clean, hygienic, and stress-free experience for patients of all ages.
• Convenient Location: Easily accessible facilities across the city make it simple for patients to undergo diagnostic testing without long commutes.
• Commitment to Accurate Diagnosis: We ensure that every sample is handled with the utmost care, from precise collection to temperature-controlled transport and analysis.